Publication | Closed Access

ERCC1, MLH1, MSH2, MSH6, and βIII-Tubulin: Resistance Proteins Associated With Response and Outcome to Platinum-based Chemotherapy in Malignant Pleural Mesothelioma

Malignant Pleural MesotheliomaMalignant DiseaseMedicineResistance ProteinsCancer Cell BiologyPathologyCancer TreatmentCancer BiologyCell BiologyCancer ResearchTumor BiologyPlatinum-based Chemotherapy